As shown in Figures 1C, D, the mRNA (Figure 1C) and protein (Figure 1D) levels of METTL3 were dramatically decreased in the breast cancer cell lines, especially in the TNBC cell lines. This evidence concerns the gene METTL3 and breast carcinoma.